G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
3.300
-0.010 (-0.30%)
At close: May 31, 2024, 4:00 PM
3.351
+0.051 (1.55%)
After-hours: May 31, 2024, 7:45 PM EDT
G1 Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for G1 Therapeutics stock have an average target of 11, with a low estimate of 4.00 and a high estimate of 19. The average target predicts an increase of 233.33% from the current stock price of 3.30.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for GTHX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +172.73% | May 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +263.64% | May 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +263.64% | May 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +172.73% | May 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +172.73% | May 2, 2024 |
Financial Forecast
Revenue This Year
73.71M
from 82.51M
Decreased by -10.67%
Revenue Next Year
100.91M
from 73.71M
Increased by 36.91%
EPS This Year
-0.56
from -0.93
EPS Next Year
-0.31
from -0.56
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 84.0M | 121.9M | 189.4M | 158.5M | 183.5M |
| Avg | 73.7M | 100.9M | 125.7M | 135.7M | 169.5M |
| Low | 60.5M | 66.5M | 76.5M | 112.2M | 158.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.8% | 65.4% | 87.7% | 26.1% | 35.2% |
| Avg | -10.7% | 36.9% | 24.5% | 8.0% | 24.9% |
| Low | -26.7% | -9.7% | -24.2% | -10.7% | 16.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.37 | -0.11 | 0.76 | 0.35 | 0.51 |
| Avg | -0.56 | -0.31 | 0.01 | 0.22 | 0.49 |
| Low | -0.63 | -0.64 | -0.49 | 0.11 | 0.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 5,126.2% | 129.3% |
| Avg | - | - | - | 3,284.6% | 120.5% |
| Low | - | - | - | 1,525.9% | 109.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.